PL365648A1 - Stabilne sole kwasu O-acetylosalicylowego z zasadowymi aminokwasami - Google Patents

Stabilne sole kwasu O-acetylosalicylowego z zasadowymi aminokwasami

Info

Publication number
PL365648A1
PL365648A1 PL01365648A PL36564801A PL365648A1 PL 365648 A1 PL365648 A1 PL 365648A1 PL 01365648 A PL01365648 A PL 01365648A PL 36564801 A PL36564801 A PL 36564801A PL 365648 A1 PL365648 A1 PL 365648A1
Authority
PL
Poland
Prior art keywords
acetylsalicyclic
amino acids
basic amino
stable salts
salts
Prior art date
Application number
PL01365648A
Other languages
English (en)
Other versions
PL204593B1 (pl
Inventor
Gerhard Franckowiak
Hubert Appolt
Gregor Leifker
Hans-Peter Wirges
Wolfram Ledwoch
Original Assignee
Bayer Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare filed Critical Bayer Healthcare
Publication of PL365648A1 publication Critical patent/PL365648A1/pl
Publication of PL204593B1 publication Critical patent/PL204593B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
PL365648A 2000-07-18 2001-07-05 Kompozycja obejmująca sól kwasu o-acetylosalicylowego z zasadowym aminokwasem, sposób jej wytwarzania, lek obejmujący co najmniej jedną powyższą kompozycję i zastosowanie powyższej kompozycji do wytwarzania leku PL204593B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10034802A DE10034802A1 (de) 2000-07-18 2000-07-18 Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
PCT/EP2001/007669 WO2002005782A2 (de) 2000-07-18 2001-07-05 Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren

Publications (2)

Publication Number Publication Date
PL365648A1 true PL365648A1 (pl) 2005-01-10
PL204593B1 PL204593B1 (pl) 2010-01-29

Family

ID=7649258

Family Applications (1)

Application Number Title Priority Date Filing Date
PL365648A PL204593B1 (pl) 2000-07-18 2001-07-05 Kompozycja obejmująca sól kwasu o-acetylosalicylowego z zasadowym aminokwasem, sposób jej wytwarzania, lek obejmujący co najmniej jedną powyższą kompozycję i zastosowanie powyższej kompozycji do wytwarzania leku

Country Status (33)

Country Link
US (2) US6773724B2 (pl)
EP (1) EP1365737B1 (pl)
JP (2) JP2004507463A (pl)
KR (1) KR100773658B1 (pl)
CN (1) CN1205176C (pl)
AR (1) AR030305A1 (pl)
AT (1) ATE293589T1 (pl)
AU (2) AU7847101A (pl)
BR (1) BR0112538A (pl)
CA (1) CA2416288C (pl)
CR (1) CR6888A (pl)
CZ (1) CZ300337B6 (pl)
DE (2) DE10034802A1 (pl)
DK (1) DK1365737T3 (pl)
EC (1) ECSP034437A (pl)
ES (1) ES2241849T3 (pl)
GT (1) GT200100134A (pl)
HR (1) HRP20030108B1 (pl)
HU (1) HUP0302053A3 (pl)
IL (2) IL153873A0 (pl)
MX (1) MXPA03000510A (pl)
MY (1) MY134521A (pl)
NO (1) NO20030222D0 (pl)
PE (1) PE20020267A1 (pl)
PL (1) PL204593B1 (pl)
PT (1) PT1365737E (pl)
RS (1) RS50329B (pl)
SK (1) SK286162B6 (pl)
SV (1) SV2002000557A (pl)
TW (1) TWI299729B (pl)
UY (1) UY26841A1 (pl)
WO (1) WO2002005782A2 (pl)
ZA (1) ZA200300469B (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
DE10202019A1 (de) * 2002-01-18 2003-07-24 Bayer Ag Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II
US8142810B2 (en) 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
ES2330321T3 (es) * 2003-05-16 2009-12-09 Cephalon France Procedimiento de sintesis de modafinilo.
CA2576971A1 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
US20060166901A1 (en) * 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
DE102005025283A1 (de) * 2005-06-02 2006-12-07 Bayer Healthcare Ag Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
DE102005049293A1 (de) * 2005-10-15 2007-04-26 Bayer Healthcare Ag Kombinationspräparate von Salzen oder o-Acetylsalicylsäure
AU2006346195B2 (en) 2006-07-09 2013-03-07 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
JP2010529101A (ja) * 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
DE102008004386A1 (de) 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
CN101314029B (zh) * 2008-06-18 2010-12-08 四川省农业科学院实验场 乙酰水杨酸肽及其制备方法
US20100120727A1 (en) * 2008-11-12 2010-05-13 Kyphia Pharmaceuticals, Inc. Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof
CN108191846B (zh) 2008-12-04 2021-08-20 于崇曦 高穿透性组合物及其应用
EP2445861B1 (en) * 2009-06-25 2014-03-26 Tetra, Sia Novel acetylsalicylic acid salts
CN101633624B (zh) * 2009-08-04 2013-05-01 蚌埠丰原医药科技发展有限公司 改进的赖氨匹林的制备方法
FR2950625B1 (fr) * 2009-09-30 2016-12-02 Holis Tech Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue
FR2965261B1 (fr) 2009-09-30 2012-10-26 Holis Technologies Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede
FR2973370B1 (fr) * 2011-03-29 2013-05-03 Holis Technologies Procede a faible cout pour la preparation d'un acide o-acetylsalicyclique et d'un acide amine basique
CN102503845A (zh) * 2011-09-28 2012-06-20 广州普星药业有限公司 一种dl-赖氨酸阿司匹林盐的制备方法及其应用
HK1207562A1 (en) 2012-01-18 2016-02-05 苏州泰飞尔医药有限公司 High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
CN102976962B (zh) * 2012-11-20 2015-02-04 南京工业大学 L-鸟氨酸阿司匹林复盐及其制备方法和应用
FR3021654B1 (fr) 2014-05-28 2016-06-24 Unither Pharmaceuticals Procede de preparation d'un sel d'acide acetylsalicylique et d'un acide amine basique
CA3044137C (en) * 2016-12-23 2021-06-15 Ventaleon Gmbh Improved synthesis of lysine acetylsalicylate · glycine particles
EP3630120A4 (en) 2017-05-30 2021-01-13 Rhoshan Pharmaceuticals, Inc. DEPOSITION IN A VIAL OF A STABLE, STERILE AND CRYSTALLINE O-ACETYL-SALICYLIC ACID (ASPIRINE)
KR20200035047A (ko) * 2017-08-03 2020-04-01 산텐 세이야꾸 가부시키가이샤 클로르헥시딘을 함유하는 의약 조성물
CN113105326A (zh) * 2021-03-24 2021-07-13 海南卓华制药有限公司 赖氨匹林的制备方法及应用
CN114478287A (zh) * 2021-12-31 2022-05-13 蚌埠丰原医药科技发展有限公司 一种赖氨匹林晶型及制备方法和应用
AU2023205426A1 (en) 2022-01-05 2024-06-13 Aspiair Gmbh Improved synthesis of lysine acetylsalicylate · glycine particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2115060A1 (en) * 1970-11-26 1972-07-07 Metabio Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin
ES388158A1 (es) * 1971-02-11 1974-03-16 Liade Sa Lab Procedimiento de obtencion de sales solubles del acido ace-til salicilico.
JPS4856815A (pl) * 1971-11-13 1973-08-09
JPS55127345A (en) * 1979-03-23 1980-10-02 Kyowa Hakko Kogyo Co Ltd Preparation of acetylsalicylic acid salt
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
JPS56113741A (en) * 1980-02-13 1981-09-07 Mitsui Toatsu Chem Inc Preparation of crystal of acetylsalicylic acid salt
JPS5721345A (en) * 1980-07-15 1982-02-04 Mitsui Toatsu Chem Inc Purification of acetylsalicylate salt
CS247688B1 (cs) * 1984-12-22 1987-01-15 Evzen Kasafirek Způsob výroby soli lysinu s kyselinou acetylsalicylovou
JPS632929A (ja) * 1986-06-20 1988-01-07 Kao Corp アセチルサリチル酸製剤
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
PT1365737E (pt) 2005-08-31
PL204593B1 (pl) 2010-01-29
HUP0302053A2 (hu) 2003-09-29
SV2002000557A (es) 2002-10-24
CZ300337B6 (cs) 2009-04-22
JP2004507463A (ja) 2004-03-11
US7449198B2 (en) 2008-11-11
KR20030019586A (ko) 2003-03-06
HUP0302053A3 (en) 2010-03-29
SK286162B6 (sk) 2008-04-07
MXPA03000510A (es) 2004-04-20
AR030305A1 (es) 2003-08-20
AU2001278471B2 (en) 2004-07-22
RS50329B (sr) 2009-09-08
DK1365737T3 (da) 2005-07-11
GT200100134A (es) 2002-03-22
JP2012131824A (ja) 2012-07-12
ES2241849T3 (es) 2005-11-01
HRP20030108A2 (en) 2005-02-28
MY134521A (en) 2007-12-31
SK672003A3 (en) 2003-06-03
WO2002005782A3 (de) 2003-10-02
KR100773658B1 (ko) 2007-11-05
WO2002005782A2 (de) 2002-01-24
CZ2003164A3 (cs) 2003-04-16
PE20020267A1 (es) 2002-06-08
HK1061811A1 (en) 2004-10-08
NO20030222L (no) 2003-01-16
CA2416288A1 (en) 2003-01-15
CA2416288C (en) 2009-12-22
CN1468209A (zh) 2004-01-14
CR6888A (es) 2004-10-28
EP1365737B1 (de) 2005-04-20
DE10034802A1 (de) 2002-01-31
IL153873A (en) 2009-05-04
TWI299729B (en) 2008-08-11
NO20030222D0 (no) 2003-01-16
ZA200300469B (en) 2004-06-21
UY26841A1 (es) 2002-02-28
US20020091108A1 (en) 2002-07-11
BR0112538A (pt) 2003-09-09
YU2003A (sh) 2006-08-17
EP1365737A2 (de) 2003-12-03
CN1205176C (zh) 2005-06-08
ATE293589T1 (de) 2005-05-15
IL153873A0 (en) 2003-07-31
HRP20030108B1 (en) 2006-12-31
ECSP034437A (es) 2003-03-31
DE50105985D1 (de) 2005-05-25
US6773724B2 (en) 2004-08-10
US20050009791A1 (en) 2005-01-13
AU7847101A (en) 2002-01-30

Similar Documents

Publication Publication Date Title
AU7847101A (en) Stable salts of o-acetylsalicyclic with basic amino acids
AU2001278471A1 (en) Stable salts of o-acetylsalicyclic with basic amino acids
HUP0300299A3 (en) Composition comprising free amino acids
HRP20020963A2 (en) Beta-amino acid nitrile derivatives
GB9806815D0 (en) Amino acid derivatives
IL154031A0 (en) Substituted sulfonylaminomethylbenzoic acid derivatives and preparation
GB0012850D0 (en) Cyclic amino acid derivatives useful as pharmaceutical agents
SI1337521T1 (sl) Soli izotiazol-4-karboksamida in njihova uporaba kot antihiperproliferacijska sredstva
PL346731A1 (en) Derivatives of diazepane or their salts
AU6785401A (en) Novel dicarboxylic acid derivatives
EP1255542A4 (en) SUBSTITUTED AMINO ACIDS AS NEUTRAL SPHINGOMYELINASE INHIBITORS
IL153441A0 (en) Stable gabapentin having ph within a controlled range
AU1497802A (en) Ss-thio-amino acids
AU3569801A (en) Amino acid derivatives and use thereof as nep, ace and ece inhibitors
IL162881A0 (en) Stable salts of o-acetylsalicylic acid containing basic amino acids ii
HUP0400737A3 (en) Use of l-carnitine for preparation of compositions for stabilizing the proteins
PL357011A1 (pl) Nowe pochodne amidowe -sulfinylo-i -sulfonyloaminokwasów
AU2001258543A1 (en) Branched amino acids
PL357715A1 (pl) Nowe pochodne amidowe alfa-sulfinylo-i alfa-sulfonyloaminokwasów
GB0025386D0 (en) Branched amino acids
GB0205126D0 (en) Stable storage of proteins
AU2002326756A1 (en) Ascorbic acid derivatives with amino acids
GB0017435D0 (en) 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivatives
SI1317426T1 (sl) Beta-tio-aminokisline
PL357012A1 (pl) Nowe amidy -sulfinylo-i -sulfonyloaminokwasów

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20110705